RecruitingPhase 1NCT06179069
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Hackensack, NJ · +10 more sites
Lung Cancer clinical trials in Hackensack, NJ
16 recruiting lung cancer studies with a site in Hackensack, NJ.
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Hackensack, NJ · +43 more sites
RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Hackensack, NJ · +10 more sites
RecruitingPhase 1 / Phase 2NCT06780137
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Sponsor: Merck Sharp & Dohme LLC
Hackensack, NJ · +8 more sites
RecruitingPhase 1NCT07164313
A Study of ZW251 in Participants With Advanced Solid Tumors
Sponsor: Zymeworks BC Inc.
Hackensack, NJ · +7 more sites
RecruitingPhase 1 / Phase 2NCT06362252
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Sponsor: Daiichi Sankyo
East Brunswick, NJ · Hackensack, NJ · +24 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Hackensack, NJ · New Brunswick, NJ · +16 more sites
RecruitingPhase 1 / Phase 2NCT07629960
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Sponsor: Blueprint Medicines Corporation
Hackensack, NJ · +9 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
East Brunswick, NJ · Hackensack, NJ · New Brunswick, NJ · +21 more sites
RecruitingPhase 1 / Phase 2NCT06892548
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Sponsor: BioNTech SE
Belleville, NJ · Hackensack, NJ · +15 more sites
RecruitingPhase 1 / Phase 2NCT04165070
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Sponsor: Merck Sharp & Dohme LLC
Hackensack, NJ · +17 more sites
RecruitingPhase 1 / Phase 2NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Sponsor: Bristol-Myers Squibb
Hackensack, NJ · +10 more sites
RecruitingPhase 1NCT06764771
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Sponsor: Bristol-Myers Squibb
Hackensack, NJ · +3 more sites
RecruitingPhase 1NCT06179160
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Sponsor: Incyte Corporation
Hackensack, NJ · +12 more sites
RecruitingPhase 1NCT07046923
A Study of LY4175408 in Participants With Advanced Cancer
Sponsor: Eli Lilly and Company
Hackensack, NJ · +14 more sites
RecruitingPhase 2NCT05726383
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Sponsor: Hackensack Meridian Health
Hackensack, NJ · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.